Company news
Bluejay Diagnostics, Inc. news in 2026
Bluejay Diagnostics, Inc.'s news releases, calls and decks from 2026, newest first.
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
October 30, 2026
Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
October 13, 2026
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
September 8, 2026
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
August 13, 2026
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
July 21, 2026
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 5, 2026
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 2, 2026
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
June 2, 2026
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
May 7, 2026
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
April 6, 2026
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
March 12, 2026
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
March 5, 2026
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
February 20, 2026
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
February 17, 2026
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
January 27, 2026